Drug or Treatment Category: Radiation Therapy

NCT05404308: Interest of a Weekly Consultation by a Medical Electro Radiology Manipulator (MERM) in Addition to the Follow-up by the Radiotherapist to Improve the Collection of Radio-induced Toxicities in Patients Undergoing Proton Therapy

NCT05404308
Breast Cancer Type: HER2+, HR+ & HER2-negative, Triple Negative
Hormone Mutations: ER+, PR+
Other Mutations: 
Breast Cancer Tissue: 
Recruitment Status: Not yet recruiting
Not Applicable
Drug Category: Radiation Therapy

Key Eligibility Criteria:

Gender: All
Age: 18 Years and older (Adult, Older Adult)
Location of Metastases: Brain
Additional Notes: Patient must be a candidate for proton therapy; Patient must speak French fluently
Exclusions: 
https://ClinicalTrials.gov/show/NCT05404308

NCT05378633: The CyberChallenge Trial How Much is Too Much – What is the Role of Cyberknife Radiosurgery in Patients With Multiple Brain Metastases?

NCT05378633
Breast Cancer Type: HER2+, HR+ & HER2-negative, Triple Negative
Hormone Mutations: ER+, PR+
Other Mutations: 
Breast Cancer Tissue: 
Recruitment Status: Recruiting
Phase 2
Drug Category: Radiation Therapy

Key Eligibility Criteria:

Gender: All
Age: 18 Years and older (Adult, Older Adult)
Location of Metastases: Brain
Additional Notes: Patients must have 4-15 suspect intracranial lesions
Exclusions: Patients with previous radiotherapy to the brain; Patients with more than 15 suspect intracranial lesions; Patients with leptomeningeal disease
https://ClinicalTrials.gov/show/NCT05378633

Up ↑